Device Trial Radar · NCT04611100
Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar Cholangiocarcinoma
Last checked: Nov 20, 2026Latest source record: Mar 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
70
Actual
Start
Apr 1, 2020
Primary completion
Dec 30, 2021
Study completion Dec 30, 2021
Sponsor
- Lead sponsor
- Department of Medical Services Ministry of Public Health of ThailandGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Nov 2, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study aim to evaluate the efficacy of intraductal radiofrequency ablation for unresetable hilar cholangiocarcinoma in addition to biliary stenting. The patient would be randomized into 1:1 ratio of conventional group who received biliary stenting alone, and RFA group who receive intraductal RFA before biliary stenting. Immediate complications as well as long term stent patency and patient survival would be studied.
Conditions
- Hilar Cholangiocarcinoma
- Biliary Obstruction
Interventions
ELRA endoluminal radiofrequency ablation electrode (Taewoong, Seoul, Korea)Device
Intraductal radiofrequency ablation using ELRA endoluminal radiofrequency ablation electrode (Taewoong, Seoul, Korea) 10W 2 minutes at the obstructed bile duct before placing uncover self-expandable biliary metal stent
Primary outcomes
What the sponsor says the trial is designed to measure.
- Biliary stent patencyTime frame: up to 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Rajavithi Hospital
Bangkok, Thailand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.